CXCL9 and viral infectious disease: In addition, the CXCL9(74-103) and COOH-terminal CXCL12γ peptides were able to inhibit viral infection of cells with dengue virus, herpes simplex virus-1 and respiratory syncytial virus due to competition with the viruses for GAG binding (43).